Join the DDA or

HRT supply notifications issued

Four updated notices

May 24th 2022

Tagged: Clinical guidance news Dispensary guidance news supply shortages

By Ailsa Colquhoun

DHSC has updated four HRT Tier 2 medicine supply notifications: .

The updated MSNs are

  • Estradiol (Oestrogel) pump pack 0.06% gel
  • Estriol (Ovestin) 1mg cream
  • Estradiol (Sandrena) 500microgram and 1mg gel sachets
  • Estradiol (Lenzetto) 1.53mg/dose transdermal spray

10 Serious Shortage Protocols are in operation for HRT products, some of which limit prescription durations to three months. View the SSPs.

The details of the MSNs are as follows:

Medicine

Out of stock

Alternatives

Estradiol (Oestrogel Pump-Pack 750microgram per actuation) 0.06% gel

Intermittent supply issues with a resolution date to be confirmed.

  • A Serious Shortage Protocol (SSP) was issued on 29/04/2022 around supply limits.
  • Two Serious Shortage Protocols (SSPs) were issued on 20/05/2022 allowing community pharmacists to supply estradiol patches where estradiol (Oestrogel Pump-Pack 750microgram per actuation) 0.06% gel is unavailable.
  • Alternative hormone replacement therapies remain available.
  • Where the above alternatives are not suitable, unlicensed supplies can be sourced.
  • See MSN for details.

Estriol (Ovestin 1mg) 0.1% cream

Intermittent supply issues until July 2022.

  • A Serious Shortage Protocol (SSP) was issued on 29/04/2022 around supply limits.
  • Alternative hormone replacement therapies remain available.
  • Where the above alternatives are not suitable, unlicensed supplies can be sourced.
  • See MSN for details.

Estradiol (Sandrena) 500microgram and 1mg gel sachets

Until early June 2022.

  • A Serious Shortage Protocol (SSP) was issued on 20/05/2022 around supply limits.
  • Alternative hormone replacement therapies remain available.
  • Where the above alternatives are not suitable, unlicensed supplies can be sourced.
  • See MSN for details.

Estradiol (Lenzetto) 1.53mg/dose transdermal spray

Limited supply until mid-July 2022.

  • A Serious Shortage Protocol (SSP) was issued on 20/05/2022 around supply limits.
  • Alternative hormone replacement therapies remain available.
  • Where the above alternatives are not suitable, unlicensed supplies can be sourced.
  • See MSN for details.

View up-to-date MSNs via the new Medicines Supply Tool (SPS registration required).